Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Thakker, D. Inverarity, P. Connell, J. Clark, M. Cotton, A. Rayner, L. Seagar, I. Laurenson (Glasgow, Edinburgh, United Kingdom). Recurrent laboratory pseudo-outbreaks of Mycobacterium intracellulare. Eur Respir J 2008; 32: Suppl. 52, 2265

Member's Comments

No comment yet.

Related content which might interest you: Invasive Mycobacterium avium intracellulare infection Source: Eur Respir J 2006; 28: Suppl. 50, 312s Year: 2006 Pulmonary diseases caused by non-tuberculous mycobacteria Source: Eur Respir Mon 2012; 58: 25-37 Year: 2012 Clinical relevance of Mycobacterium malmoense isolation in the Netherlands Source: Eur Respir J 2009; 34: 926-931 Year: 2009 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Mycobacterium xenopi pulmonary disease in Croatia Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016 Year: 2017 No human transmission of Mycobacterium malmoense in a perfect storm setting Source: Eur Respir J 2012; 40: 1576-1578 Year: 2012 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Nontuberculous mycobacterial infections Source: Eur Respir Mon 2011; 52: 115-129 Year: 2011 Genotyping of human Mycobacterium kansasii isolates from Poland. Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Emerging untreatable non-tuberculous pulmonary disease due to Mycobacterium abscessus Source: Eur Respir J 2004; 24: Suppl. 48, 415s Year: 2004 The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi) Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Pulmonary mycobacterium xenopi infection in Japan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008 Human-to-human transmission of Mycobacterium kansasii or victims of a shared source? Source: Eur Respir J 2014; 44: 1085-1087 Year: 2014